110 related articles for article (PubMed ID: 15110627)
21. Histomorphological and functional impacts of postoperative motor training in rats after allograft sciatic nerve transplantation under low-dose FK 506.
Rustemeyer J; Krajacic A; Dicke U
Muscle Nerve; 2009 Apr; 39(4):480-8. PubMed ID: 19260056
[TBL] [Abstract][Full Text] [Related]
22. Recipient damage after musculocutaneous transplant rejection.
Horner BM; Eberlin KR; Ferguson KK; Hirsh EL; Randolph MA; Butler PE
Transplantation; 2008 Oct; 86(8):1104-10. PubMed ID: 18946349
[TBL] [Abstract][Full Text] [Related]
23. Alloantigen-pulsed host dendritic cells induce T-cell regulation and prolong allograft survival in a rat model of hindlimb allotransplantation.
Kuo YR; Huang CW; Goto S; Wang CT; Hsu LW; Lin YC; Yang KD; Chen CL; Lee WP
J Surg Res; 2009 May; 153(2):317-25. PubMed ID: 19101689
[TBL] [Abstract][Full Text] [Related]
24. Donor-derived transplant acceptance-inducing cells in composite tissue allotransplantation.
Radu CA; Horn D; Kiefer J; Rebel M; Gebhard MM; Ryssel H; Köllensperger E; Fändrich F; Germann G; Kremer T
J Plast Reconstr Aesthet Surg; 2012 Dec; 65(12):1684-91. PubMed ID: 22841770
[TBL] [Abstract][Full Text] [Related]
25. Immunomodulation with anti-alphabeta T-cell receptor monoclonal antibodies in combination with cyclosporine A improves regeneration in nerve allografts.
Scharpf J; Strome M; Siemionow M
Microsurgery; 2006; 26(8):599-607. PubMed ID: 17066409
[TBL] [Abstract][Full Text] [Related]
26. Intraosseus transplantation of donor-derived hematopoietic stem and progenitor cells induces donor-specific chimerism and extends composite tissue allograft survival.
Siemionow M; Zielinski M; Ozmen S; Izycki D
Transplant Proc; 2005 Jun; 37(5):2303-8. PubMed ID: 15964405
[TBL] [Abstract][Full Text] [Related]
27. Functional outcome after facial allograft transplantation in rats.
Landin L; Cavadas PC; Gonzalez E; Rodriguez JC; Caballero A
J Plast Reconstr Aesthet Surg; 2008 Sep; 61(9):1034-43. PubMed ID: 18621596
[TBL] [Abstract][Full Text] [Related]
28. Electroporation-mediated interleukin-10 overexpression in skeletal muscle reduces acute rejection in rat cardiac allografts.
Tavakoli R; Gazdhar A; Pierog J; Bogdanova A; Gugger M; Pringle IA; Gill DR; Hyde SC; Genoni M; Schmid RA
J Gene Med; 2006 Feb; 8(2):242-8. PubMed ID: 16389627
[TBL] [Abstract][Full Text] [Related]
29. Effect of immunosuppression on survival of allograft limbal stem cells.
Chen W; Cao L; Hara K; Yoshitomi T
Jpn J Ophthalmol; 2004; 48(5):440-7. PubMed ID: 15486765
[TBL] [Abstract][Full Text] [Related]
30. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
[TBL] [Abstract][Full Text] [Related]
31. A long-term study of allogeneic rat hindlimb transplants immunosuppressed with RS-61443.
Benhaim P; Anthony JP; Lin LY; McCalmont TH; Mathes SJ
Transplantation; 1993 Oct; 56(4):911-7. PubMed ID: 8212216
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of a topical cyclosporine A prodrug on corneal graft rejection in rats.
Bourges JL; Lallemand F; Agla E; Besseghir K; Dumont JM; BenEzra D; Gurny R; Behar-Cohen F
Mol Vis; 2006 Dec; 12():1461-6. PubMed ID: 17167400
[TBL] [Abstract][Full Text] [Related]
33. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
Pretagostini R; Cinti P; Lai Q; Poli L; Berloco PB
Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959
[TBL] [Abstract][Full Text] [Related]
34. Effect of prophylaxis with low-dose anti-thymocyte globulin on prevention of acute kidney allograft rejection.
Khosroshahi HT; Tubbs RS; Shoja MM; Ghafari A; Noshad H; Ardalan MR
Transplant Proc; 2008; 40(1):137-9. PubMed ID: 18261569
[TBL] [Abstract][Full Text] [Related]
35. FTY720, a novel immunomodulator: efficacy and safety results from the first phase 2A study in de novo renal transplantation.
Tedesco-Silva H; Mourad G; Kahan BD; Boira JG; Weimar W; Mulgaonkar S; Nashan B; Madsen S; Charpentier B; Pellet P; Vanrenterghem Y
Transplantation; 2004 Jun; 77(12):1826-33. PubMed ID: 15223899
[TBL] [Abstract][Full Text] [Related]
36. Assessment of the risk of chronic allograft dysfunction after renal transplantation in a randomized cyclosporine withdrawal trial.
Hazzan M; Buob D; Labalette M; Provot F; Glowacki F; Hoffmann M; Copin MC; Noel C
Transplantation; 2006 Sep; 82(5):657-62. PubMed ID: 16969289
[TBL] [Abstract][Full Text] [Related]
37. One-year outcomes in simultaneous kidney-pancreas transplant recipients receiving an alternative dosing regimen of daclizumab.
Stratta RJ; Alloway RR; Lo A; Hodge EE;
Transplant Proc; 2004 May; 36(4):1080-1. PubMed ID: 15194375
[TBL] [Abstract][Full Text] [Related]
38. Post-kidney transplant surgical complications under new immunosuppressive regimens.
Burgos FJ; Pascual J; Quicios C; Marcen R; Fernández A; López Fando L; Ortuño J
Transplant Proc; 2006 Oct; 38(8):2445-7. PubMed ID: 17097962
[TBL] [Abstract][Full Text] [Related]
39. The effects of different immunosuppressants on chronic allograft nephropathy by affecting the transforming growth factor-beta and Smads signal pathways.
Gao R; Lu Y; Xin YP; Zhang XH; Wang J; Li YP
Transplant Proc; 2006 Sep; 38(7):2154-7. PubMed ID: 16980029
[TBL] [Abstract][Full Text] [Related]
40. Effect of X-ray irradiation on limb allograft rejection in adult rats.
Ma ZL; Pei GX; Zhu LJ; Shi YS; Chen LH; Zheng JL; Wang K; Chen B; Wei KH
Di Yi Jun Yi Da Xue Xue Bao; 2002 Jun; 22(6):509-11. PubMed ID: 12297470
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
